Cargando…

Universal Screening for Lynch Syndrome Compared with Pedigree-Based Screening: 10-Year Experience in a Tertiary Hospital

PURPOSE: Universal screening for Lynch syndrome (LS) refers to routine tumor testing for microsatellite instability (MSI) among all patients with colorectal cancer (CRC). Despite its widespread adoption, real-world data on the yield is lacking in Korean population. We studied the yield of adopting u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Min Hyun, Kim, Duck-Woo, Lee, Hye Seung, Bang, Su Kyung, Seo, Soo Hyun, Park, Kyung Un, Oh, Heung-Kwon, Kang, Sung-Bum
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873326/ https://www.ncbi.nlm.nih.gov/pubmed/35313100 http://dx.doi.org/10.4143/crt.2021.1512

Ejemplares similares

A simplified two-marker immunohistochemistry strategy for Lynch syndrome screening in endometrial cancer patients
por: Aiob, Ala, et al.
Publicado: (2023)

Comparison of oncologic outcomes between patients with Lynch syndrome and sporadic microsatellite instability-high colorectal cancer
por: Son, Il Tae, et al.
Publicado: (2021)

Digital polymerase chain reaction for detecting c-MYC copy number gain in tissue and cell-free plasma samples of colorectal cancer patients
por: Lee, Kyu Sang, et al.
Publicado: (2019)

Tissue miR-200c-3p and circulating miR-1290 as potential prognostic biomarkers for colorectal cancer
por: Kang, Enoch, et al.
Publicado: (2022)

Markers for Screening Lynch Syndrome Are Reliable and Useful for Identifying the Specimen Mislabeling
por: Byeon, Sun-ju, et al.
Publicado: (2012)

Comparison of Molecular, Clinicopathological, and Pedigree Differences Between Lynch-Like and Lynch Syndromes
por: Xu, Yun, et al.
Publicado: (2020)

Clinicopathological Features and Type of Surgery for Lynch Syndrome: Changes during the Past Two Decades
por: Son, Il Tae, et al.
Publicado: (2016)

Ligand-Independent Epidermal Growth Factor Receptor Overexpression Correlates with Poor Prognosis in Colorectal Cancer
por: Yun, Sumi, et al.
Publicado: (2018)

Income Disparities in the Use of Health Screening Services Among University Students in Korea: A Cross-Sectional Study of 2479 Participants in a University
por: Lee, Su Hyun, et al.
Publicado: (2016)

The practice of universal screening for Lynch syndrome in newly diagnosed endometrial carcinoma
por: Wang, Aifen, et al.
Publicado: (2018)

Evaluating the impact of universal Lynch syndrome screening in a publicly funded healthcare system
por: Lee, Petra W. C., et al.
Publicado: (2020)

Identification of a novel pathogenic MLH1 mutation and recommended genetic screening strategy: An investigation of three Chinese Lynch syndrome pedigrees
por: Li, Fan, et al.
Publicado: (2020)

Universal molecular screening does not effectively detect Lynch syndrome in clinical practice
por: Brennan, Beatrice, et al.
Publicado: (2017)

Machine Learning for Recurrence Prediction of Gynecologic Cancers Using Lynch Syndrome-Related Screening Markers
por: Kim, Byung Wook, et al.
Publicado: (2021)

Comparative analysis of the EGFR, HER2, c-MYC, and MET variations in colorectal cancer determined by three different measures: gene copy number gain, amplification status and the 2013 ASCO/CAP guideline criterion for HER2 testing of breast cancer
por: Kwak, Yoonjin, et al.
Publicado: (2017)

Universal screening for Lynch syndrome in uterine cancer patients: A quality improvement initiative
por: Spinosa, Daniel, et al.
Publicado: (2021)

Lynch Syndrome Identification in Saudi Cohort of Endometrial Cancer Patients Screened by Universal Approach
por: Bu, Rong, et al.
Publicado: (2022)

The Source and Credibility of Colorectal Cancer Information on Twitter
por: Park, SoHyun, et al.
Publicado: (2016)

Expression of human leukocyte antigen class I and β2‐microglobulin in colorectal cancer and its prognostic impact
por: Na, Hee Young, et al.
Publicado: (2020)

Comparison of suspected Lynch syndrome patients carrying BRCA and BRCA‐like variants with Lynch syndrome probands: Phenotypic characteristics and pedigree analyses
por: Xu, Yun, et al.
Publicado: (2020)

Impact of Tumor Regression Grade as a Major Prognostic Factor in Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy: A Proposal for a Modified Staging System
por: Song, Changhoon, et al.
Publicado: (2018)

Universal tumor screening for Lynch syndrome: Perceptions of Canadian pathologists and genetic counselors of barriers and facilitators
por: Dicks, Elizabeth, et al.
Publicado: (2019)

Universal tumor screening for lynch syndrome on colorectal cancer biopsies impacts surgical treatment decisions
por: Vazzano, Jennifer, et al.
Publicado: (2022)

Functional Characterization of a Missense Variant of MLH1 Identified in Lynch Syndrome Pedigree
por: Zaib, Tahir, et al.
Publicado: (2020)

Association between microsatellite instability and tumor response to neoadjuvant chemoradiotherapy for rectal cancer
por: Lee, Soo Young, et al.
Publicado: (2022)

Lynch syndrome: barriers to and facilitators of screening and disease management
por: Watkins, Kathy E, et al.
Publicado: (2011)

Sporadic and Lynch syndrome-associated mismatch repair-deficient brain tumors
por: Kim, Hyunhee, et al.
Publicado: (2021)

Oncologic comparison between nonradical management and total mesorectal excision in good responders after chemoradiotherapy in patients with mid-to-low rectal cancer
por: Lee, Ja Kyung, et al.
Publicado: (2021)

GLUT-1 may predict metastases and death in patients with locally advanced rectal cancer
por: Kim, Tae Hyun, et al.
Publicado: (2023)

Pyloric Gland Adenoma in Lynch Syndrome
por: Lee, Seung Eun, et al.
Publicado: (2014)

Universal tumor screening for Lynch syndrome: Assessment of the perspectives of patients with colorectal cancer regarding benefits and barriers
por: Hunter, Jessica Ezzell, et al.
Publicado: (2015)

Economic Evaluation of Universal Lynch Syndrome Screening Protocols among Newly Diagnosed Patients with Colorectal Cancer
por: Hao, Jing, et al.
Publicado: (2021)

Identifying patients with Lynch syndrome using a universal tumor screening program in an integrated healthcare system
por: Crain, Philip R., et al.
Publicado: (2022)

Screening and identification of Lynch syndrome: a systematic review of the frequency of Lynch syndrome-associated clinicopathologic and molecular characteristics in Lynch syndrome gynecologic cancers
por: Yang, Zihui, et al.
Publicado: (2021)

Retracted: Functional Characterization of a Missense Variant of MLH1 Identified in Lynch Syndrome Pedigree
por: Markers, Disease
Publicado: (2023)

Follow-Up Intervals for Breast Imaging Reporting and Data System Category 3 Lesions on Screening Ultrasound in Screening and Tertiary Referral Centers
por: Huh, Sun, et al.
Publicado: (2020)

BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis
por: Nam, Soo Kyung, et al.
Publicado: (2016)

Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database report
por: Dominguez-Valentin, Mev, et al.
Publicado: (2019)

Audit of adherence to GI screening recommendations for Lynch Syndrome Patients
por: Hossack, Lucinda, et al.
Publicado: (2012)

Single-center study of Lynch syndrome screening in colorectal polyps
por: Zhu, FangChao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qc81lchm3817mt83lakhaaaquj